Connect with us

Hi, what are you looking for?

Health

6-Year-Old Child Dies From RSV in Michigan, Cases Continue to Spike in the Country

RSV
RSV cases continue to spike across the country. (Photo: Healthline)

A 6-year-old child died after developing complications from respiratory syncytial virus (RSV), the Michigan health officials confirmed the report.

RSV

RSV cases continue to spike across the country. (Photo: Healthline)

A 6-Year-Old Child Dies from RSV

A news outlet reports that a 6-year-old child died from RSV. The child is reportedly a young boy from Detroit whose family asked the news outlets not to name the child. Meanwhile, they did not give other details about the death of the child.

On the other hand, cases of RSV across the country continue to spike. They observed an alarming increase in RSV cases among children in recent weeks. Symptoms of RSV include the following:

  • Runny nose
  • Coughing
  • Fever
  • Loss of appetite

According to the Centers for Disease Control and Prevention (CDC), infants and older adults age, age 65 years old and above, can develop more serious complications once they get infected with the virus.

READ ALSO: Itchy Skin Is A Sign Of Pancreatic Cancer; Pancreatic Cancer Action Says

Experts Released Statements

Dr. Matthew Denenberg, chief of pediatrics at Corewell Health East in Michigan told a news outlet, “We’ve seen about a 500% increase in positive tests in children that have been admitted for upper respiratory infection. Very, very few children die from RSV, and the kids that get that sick, it’s usually a child that has an underlying illness”.

Meanwhile, Dr. James Schneider, chief of pediatric critical care at Cohen Children’s Medical Center said, “We’re giving a lot of support that often requires inhalation therapies — sometimes steroids, sometimes breathing machines like ventilators until the virus itself works its way out”.

Is there a Treatment?

Good Morning America (GMA) reports that there is no approved vaccine or treatment for RSV in the country. However, European Commission this week approved a new monoclonal antibody injection, Beyfortus. It is intended to provide partial immunity for newborns and babies up to 1 year old.

READ ALSO: Is It True That Dogs Can Detect Cancer? Here’s What You Should Know